000 | 01672 a2200445 4500 | ||
---|---|---|---|
005 | 20250517032000.0 | ||
264 | 0 | _c20160321 | |
008 | 201603s 0 0 eng d | ||
022 | _a1791-2423 | ||
024 | 7 |
_a10.3892/ijo.2015.2982 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYi, Yong Weon | |
245 | 0 | 0 |
_aDual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6. _h[electronic resource] |
260 |
_bInternational journal of oncology _cJul 2015 |
||
300 |
_a122-32 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aDown-Regulation |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGefitinib |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndoles _xpharmacology |
650 | 0 | 4 | _aPeptide Library |
650 | 0 | 4 |
_aPiperazines _xpharmacology |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-met _xantagonists & inhibitors |
650 | 0 | 4 |
_aQuinazolines _xpharmacology |
650 | 0 | 4 |
_aRibosomal Protein S6 _xmetabolism |
650 | 0 | 4 |
_aSulfonamides _xpharmacology |
650 | 0 | 4 |
_aTriple Negative Breast Neoplasms _xdrug therapy |
700 | 1 | _aYou, Kyusic | |
700 | 1 | _aBae, Edward Jeong | |
700 | 1 | _aKwak, Sahng-June | |
700 | 1 | _aSeong, Yeon-Sun | |
700 | 1 | _aBae, Insoo | |
773 | 0 |
_tInternational journal of oncology _gvol. 47 _gno. 1 _gp. 122-32 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3892/ijo.2015.2982 _zAvailable from publisher's website |
999 |
_c24882685 _d24882685 |